31st October 2022 Product update: Aalto Bio Reagents Ltd
Aalto Bio Reagents Launches New Monkeypox Virus B21R-BSA Conjugate Peptides for Diagnostic Testing
Aalto Bio Reagents Ltd. has announced the availability of its new peptides for Monkeypox virus (MPV) B21R- and B21R-B - BSA conjugate.
MPV belongs to the Orthopoxvirus genus of the Poxviridae family, which is the same genus as the variola virus (the cause of smallpox). Orthopoxviruses have highly conserved genomes, which can lead to significant antibody cross-reactivity among its members. The development of a standard antibody test for MPV is complicated by cross-reactive immune responses induced by vaccina, the virus used in smallpox vaccines.
Aalto Bio’s new MPV peptides contain the surface glycoprotein B21R and this region contains important antibody targets as well as several key immunodominant epitopes. When conjugated to a carrier protein like BSA, this has been shown to greatly improve the sensitivity of the assay compared to unconjugated peptide, and enhance stability.
Date Published: 31st October 2022
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.